Pharmabiz
 

'BioAsia-2013' to be held in Hyderabad from Jan 28 to 30

Our Bureau, MumbaiSaturday, January 19, 2013, 08:00 Hrs  [IST]

The 10th edition of the ‘BioAsia’, the global platform for biotechnology and life sciences, will be held at the Hyderabad International Convention Centre (HICC), Hyderabad from January 28 to 30, 2013.

‘BioAsia’ is being held to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the biotechnology industry by offering a vibrant global platform for convergence of the key stakeholders --- biotech & biopharma companies, research institutions, academia, investors, service providers, policy makers, regulators and analysts.

It is a dynamic platform for companies to exhibit, launch and showcase their unique strengths, products and services. ‘BioAsia’ is playing the role of a key catalyst in mobilizing all elements that are required to drive the growth of the emerging industry of biotechnology as well as optimize the immense business potential of biotech.

According to the organisers, for the first time ‘BioAsia’ this year will witness the participation of top officials from biopharma, biotech and health regulatory agencies from across the globe. Regulatory officials from South Africa, Sri Lanka, Philippines, Czech Republic, Malaysia, Jordan, republic of Lithuania, Ghana, London, Sweden and India will be participating in the event.

Commenting on the development, Shakthi Nagappan, CEO, ‘BioAsia’ said, “BioAsia’s growing prominence as an influential and industry shaping platform for biotechnology and biopharma has drawn the attention of the regulatory community. Participation of these regulators – a very significant section, who shape the industry, is a boost for the platform and will greatly benefit the participating companies.”

The participating regulators will provide a broader perspective of understanding on the existing regulations pursued in their respective markets and across the globe leading to an in-depth understanding on the existing regulatory frameworks and requirements. This knowledge thereby will benefit the Indian companies interested in expanding their business operations and establishing footprints in these regions through exports, joint ventures, marketing, R&D, etc.

 
[Close]